A -year-old man with a history of hypertension undergoes an abdominal ultrasound for mild right upper quadrant pain. The ultrasound incidentally identifies a -cm solid mass in the right adrenal gland. Subsequent biochemical screening for hypercortisolism, primary aldosteronism, and pheochromocytoma is entirely normal. Arrange the following diagnostic modalities in the correct evidence-based sequence for characterizing this adrenal incidentaloma, starting with the initial preferred imaging study and ending with the most invasive diagnostic step of last resort.
- 1Non-contrast computed tomography (CT) of the adrenal glands
- 2Adrenal protocol CT with delayed contrast washout imaging
- 3Fluorodeoxyglucose positron emission tomography (FDG-PET) scan
- 4Image-guided percutaneous core needle biopsy
Answer
The correct sequence for characterizing an indeterminate adrenal incidentaloma is: Non-contrast CT, followed by Adrenal protocol CT with washout, then FDG-PET scan, and finally Image-guided percutaneous biopsy.
The algorithm for evaluating an adrenal incidentaloma follows a strict sequence from least invasive and most specific for common benign lesions, to most invasive for indeterminate masses. A non-contrast CT easily identifies benign lipid-rich adenomas (the most common finding). If the mass is lipid-poor ( HU), a contrast-enhanced washout CT distinguishes rapidly washing-out adenomas from malignancies. If still indeterminate, functional imaging like an FDG-PET scan assesses metabolic activity. Finally, an image-guided biopsy is reserved solely for masses remaining indeterminate when tissue diagnosis will change the management plan.
Step-by-Step Solution
Key Concept
The stepwise radiologic evaluation of an adrenal incidentaloma prioritizes non-invasive characterization based on lipid content and vascular washout before considering functional imaging or invasive biopsy.
Alternative Method
Chemical shift magnetic resonance imaging (MRI) can be utilized as a direct alternative to the adrenal protocol CT with contrast washout for the second step of characterization. Chemical shift MRI detects microscopic intracellular lipid by demonstrating a diagnostic loss of signal intensity on out-of-phase images compared to in-phase images.
Estimated Time:1m 30s